Literature DB >> 19373511

Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma.

Yoshihiko Chiba1, Satoshi Onoda, Yoshiyuki Hattori, Yoshie Maitani, Hiroyasu Sakai, Miwa Misawa.   

Abstract

Recent microarray analyses revealed that a disintegrin and metalloproteinase (ADAM) 8 (ADAM8; also called CD156) is one of the asthma candidate genes. However, the function of ADAM8 and its localization in the airways are still poorly understood. In the present study, the changes in the expression and localization of ADAM8 in the airways of a mouse model of allergic bronchial asthma were investigated. Male BALB/c mice were sensitized and repeatedly challenged with ovalbumin antigen to induce asthmatic response. After the final antigen challenge, mRNA and protein expressions of ADAM8 were elucidated by quantitative RT-PCR and immunohistochemistry. The mRNA expression of ADAM8 in the airways was significantly increased in this animal model of asthma compared with naive animals. Immunohistochemical examinations revealed that ADAM8 was located in airway epithelia, airway smooth muscles, and infiltrated cells (mainly macrophages) into lung parenchyma. A distinctly stronger immunostaining of ADAM8 was observed in these airway cells of the repeatedly antigen-challenged mice compared with those of the sensitized control animals. An upregulation of ADAM8 in the airways might be involved in the pathogenesis of airway inflammation and/or hyperresponsiveness, characteristic features of allergic bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19373511     DOI: 10.1007/s00408-009-9145-7

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  30 in total

Review 1.  Shedding light on ADAM metalloproteinases.

Authors:  Ari-Pekka J Huovila; Anthony J Turner; Markku Pelto-Huikko; Iivari Kärkkäinen; Rebekka M Ortiz
Journal:  Trends Biochem Sci       Date:  2005-07       Impact factor: 13.807

2.  Expression of ADAMs and their inhibitors in sputum from patients with asthma.

Authors:  Geneviève Paulissen; Natacha Rocks; Florence Quesada-Calvo; Philippe Gosset; Jean-Michel Foidart; Agnès Noel; Renaud Louis; Didier D Cataldo
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

3.  A new role for CD23 in inflammation.

Authors:  J Y Bonnefoy; C Plater-Zyberk; S Lecoanet-Henchoz; J F Gauchat; J P Aubry; P Graber
Journal:  Immunol Today       Date:  1996-09

4.  Hyperresponsiveness of bronchial but not tracheal smooth muscle in a murine model of allergic bronchial asthma.

Authors:  Y Chiba; A Ueno; H Sakai; M Misawa
Journal:  Inflamm Res       Date:  2004-11       Impact factor: 4.575

5.  Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma.

Authors:  Nina E King; Nives Zimmermann; Samuel M Pope; Patricia C Fulkerson; Nikolaos M Nikolaidis; Anil Mishra; David P Witte; Marc E Rothenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2004-04-15       Impact factor: 6.914

6.  CD23 and allergic pulmonary inflammation: potential role as an inhibitor.

Authors:  M Cernadas; G T De Sanctis; S J Krinzman; D A Mark; C E Donovan; J A Listman; L Kobzik; H Kikutani; D C Christiani; D L Perkins; P W Finn
Journal:  Am J Respir Cell Mol Biol       Date:  1999-01       Impact factor: 6.914

7.  Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8.

Authors:  Silvia Naus; Simone Reipschläger; Dirk Wildeboer; Stefan F Lichtenthaler; Stefan Mitterreiter; Ziqiang Guan; Marcia L Moss; Jörg W Bartsch
Journal:  Biol Chem       Date:  2006-03       Impact factor: 3.915

8.  CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness.

Authors:  A Haczku; K Takeda; E Hamelmann; J Loader; A Joetham; I Redai; C G Irvin; J J Lee; H Kikutani; D Conrad; E W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2000-03       Impact factor: 21.405

9.  Effects of nano particles on antigen-related airway inflammation in mice.

Authors:  Ken-ichiro Inoue; Hirohisa Takano; Rie Yanagisawa; Miho Sakurai; Takamichi Ichinose; Kaori Sadakane; Toshikazu Yoshikawa
Journal:  Respir Res       Date:  2005-09-16

10.  Regulation of cytokine production by soluble CD23: costimulation of interferon gamma secretion and triggering of tumor necrosis factor alpha release.

Authors:  M Armant; H Ishihara; M Rubio; G Delespesse; M Sarfati
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  5 in total

1.  IL-5-stimulated eosinophils adherent to periostin undergo stereotypic morphological changes and ADAM8-dependent migration.

Authors:  M W Johansson; M Khanna; V Bortnov; D S Annis; C L Nguyen; D F Mosher
Journal:  Clin Exp Allergy       Date:  2017-05-05       Impact factor: 5.018

2.  Adam8 limits the development of allergic airway inflammation in mice.

Authors:  Martin D Knolle; Takahiro Nakajima; Anja Hergrueter; Kushagra Gupta; Francesca Polverino; Vanessa J Craig; Susanne E Fyfe; Muhammad Zahid; Perdita Permaul; Manuela Cernadas; Gilbert Montano; Yohannes Tesfaigzi; Lynette Sholl; Lester Kobzik; Elliot Israel; Caroline A Owen
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

Review 3.  Role of ADAM and ADAMTS metalloproteinases in airway diseases.

Authors:  Genevieve Paulissen; Natacha Rocks; Maud M Gueders; Celine Crahay; Florence Quesada-Calvo; Sandrine Bekaert; Jonathan Hacha; Mehdi El Hour; Jean-Michel Foidart; Agnes Noel; Didier D Cataldo
Journal:  Respir Res       Date:  2009-12-24

4.  Evolutionary divergence and functions of the ADAM and ADAMTS gene families.

Authors:  Chad N Brocker; Vasilis Vasiliou; Daniel W Nebert
Journal:  Hum Genomics       Date:  2009-10       Impact factor: 4.639

5.  A novel peptide ADAM8 inhibitor attenuates bronchial hyperresponsiveness and Th2 cytokine mediated inflammation of murine asthmatic models.

Authors:  Jun Chen; Linhong Deng; Daniela Dreymüller; Xuemei Jiang; Jiaoyue Long; Yiyuan Duan; Yue Wang; Mingzhi Luo; Feng Lin; Lizhen Mao; Bernd Müller; Garrit Koller; Jörg W Bartsch
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.